1. Clonal Upregulation of Effector Cytotoxic T Lymphocytes in a Patient with Multiple Tyrosine Kinase Inhibitor-Refractory Chronic Myeloid Leukemia with Long-Term Survival
   Tatsuro Jo et al, 2021, Case Reports in Oncology CrossRef
2. Src Tyrosine Kinase Inhibitors: New Perspectives on Their Immune, Antiviral, and Senotherapeutic Potential
   José Rivera-Torres et al, 2019, Frontiers in Pharmacology CrossRef
3. Immunomodulatory Activity of Tyrosine Kinase Inhibitors to Elicit Cytotoxicity Against Cancer and Viral Infection
   Núria Climent et al, 2019, Frontiers in Pharmacology CrossRef
4. Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells
   Mattias Carlsten et al, 2019, Frontiers in Immunology CrossRef
5. Novel Treatment Strategies Utilizing Immune Reactions against Chronic Myelogenous Leukemia Stem Cells
   Maiko Matsushita, 2021, Cancers CrossRef
6. Imatinib Analogs in Chronic Myeloid Leukemia: a Systematic Qualitative Review
   Kavita Sangwan et al, 2023, Current Pharmacology Reports CrossRef